Auto-Injectors Market Explores New Growth Opportunities

1
Global Auto-Injectors Market to Witness 18.6
CAGR during 2017 2023
2
Auto-Injectors Market
According to a new market research report Global
Auto-Injectors Market Size, Share, Development,
Growth and Demand Forecast to 2023 - Industry
Insight by Product (Prefilled, Fillable), by
Manufacturing Design (Standardized, Customized),
by Therapeutic Application (Anaphylaxis, Multiple
Sclerosis, Rheumatoid Arthritis, Others)
published by PS Market Research, the global
auto-injectors market is expected to grow at a
CAGR of 18.6 during 2017 - 2023. Explore Report
Description at https//www.psmarketresearch.com/m
arket-analysis/auto-injectors-market
3
Auto-Injectors Market
Rising prevalence of anaphylaxis drive the global
market
According to the study, the global auto-injectors
market is likely to grow significantly during the
forecast period, due to increasing prevalence of
anaphylaxis, increasing cases with multiple
sclerosis, rising geriatric population and high
production of biologics. Additionally, increasing
healthcare spending and various beneficial
features of auto-injectors also contribute to the
growth of the overall market. However, high cost
of auto-injectors and stringent regulatory
requirements are some of the key factors
restraining the growth of global auto-injectors
market.
4
Auto-Injectors Market
Insights on market segments
As per the findings of the research, the
prefilled auto-injectors is the larger product
category in the global auto-injectors market,
primarily due to increasing availability of user
friendly prefilled auto-injectors in disposable
form. Based on manufacturing design, standardized
auto-injector was the larger contributor to the
global auto-injectors market in comparison to
customized auto-injector in 2016. Anaphylaxis was
the largest application for auto-injectors,
followed by multiple sclerosis, rheumatoid
arthritis and other diseases, in 2016. According
to World Allergy Organization (WAO), the
prevalence of anaphylaxis ranged from 2 of the
population in the US, to 0.1 of the population
in Korea, and 0.6 to 1 of the population in
Australia.
5
Auto-Injectors Market
North America stands as the largest
auto-injectors market
Geographically, North America has been the
largest market for auto-injectors, with the U.S.
being the larger contributor to the regional
market, compared to Canada. Increasing cases with
diabetes and anaphylaxis, rising geriatric
population, and increasing production of
biologics are some of the factors that have been
driving the growth of the North American
auto-injectors market. North America is expected
to contribute over 67.0 to the global
auto-injectors market by 2023. The U.K. has been
the largest contributor to the European
auto-injectors market, followed by Germany and
France. The auto-injectors market is expected to
witness the fastest growth in Asia-Pacific during
2017 - 2023, owing to increasing cases of
anaphylaxis, increasing awareness about
needle-stick injuries, increasing healthcare
expenditure, and growing geriatric population.
6
Auto-Injectors Market
Emerging biologic drug therapies largely impacts
the market
Globally, the increasing demand for biologics has
been playing a key role in the growth of the
auto-injectors market. The rapidly increasing
burden of anaphylaxis, multiple sclerosis,
rheumatoid arthritis and other diseases further
compels government organizations and healthcare
providers to provide improved facilities for
effective disease treatment, leading to rising
number of launches of technologically advanced
products, globally. Most of the biologics, such
as monoclonal antibodies, anticoagulants, and
vaccines are large molecules which need to be
administered parenterally to achieve the desired
therapeutic effects. The demand for development
of injectable biologic therapies is increasing,
since many peptides break down too quickly in the
stomach and after which they no longer remain
useful for treatment. Also, various biologic
drugs and vaccines require to be injected
directly into the bloodstream. The introduction
of biosimilars would enforce the usage of
injectable in auto-injectors, and thus the
consumption and demand of auto-injectors is
expected to increase.
7
Auto-Injectors Market
Globally, the pharmaceutical industry is
observing a shift from administration of
injections in clinician settings to home care
setting. The medical device manufacturers are
also shifting their focus towards the development
of user friendly and patient compliant devices.
The point-of-care medication administration is
increasing due to improving medical services at
the bed side. The auto-injectors have emerged as
an impact of this change in the medical industry.
Auto-injectors meet the demand of physicians and
patients for easy and effective drug
administration methods. They also help to reduce
medication error and increase safety and
convenience. The popularity of auto-injector
devices is increasing due to reduced treatment
cost and facilitating patients in
self-administering their medication, thus leading
to the growth of the global auto-injectors market.
8
Auto-Injectors Market
Key players in the market are collaborating to
offer advanced auto-injectors
Key companies in the auto-injectors market is
collaborating to offer advanced auto-injectors.
In March 2017, Mylan N.V. entered in a global
settlement and license agreement with Genentech
Inc and Roche Holding AG in relation to patents
for Herceptin (trastuzumab), which provides Mylan
N.V. with global licenses for its trastuzumab
product. This is expected to help Mylan N.V. to
commercialize trastuzumab globally, except in
Japan, Brazil and Mexico. Some of the key players
operating in the global auto-injectors market
include Mylan N.V., Antares Pharma Inc., Becton,
Dickinson Co., Eli Lilly and Company, Pfizer,
Inc., Bayer AG, Novartis International AG,
Bristol-Myer Squibb, Novartis AG, Amgen Inc. and
Biogen Inc.
9
Auto-Injectors Market
Download report sample at
https//www.psmarketresearch.com/market-analysis/a
uto-injectors-market/report-sample
10
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886